argenx SE (ARGX)
605.92
+9.18
(+1.54%)
USD |
NASDAQ |
Nov 22, 16:00
597.01
-8.91
(-1.47%)
After-Hours: 20:00
argenx Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | |
| December 31, 2023 | 0.00 |
| September 30, 2023 | |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | |
| June 30, 2022 | 0.00 |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | |
| June 30, 2021 | 0.00 |
| March 31, 2021 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | |
| June 30, 2019 | 0.00 |
| March 31, 2019 | |
| December 31, 2018 | 0.00 |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
| September 30, 2017 | |
| June 30, 2017 | 0.00 |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | |
| June 30, 2016 | 0.00 |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | |
| June 30, 2015 | 0.00 |
| March 31, 2015 | |
| December 31, 2014 | 0.00 |
| September 30, 2014 | |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
--
Maximum
Dec 2019
--
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Biodexa Pharmaceuticals PLC | -- |
| uniQure NV | 0.9157 |
| ProQR Therapeutics NV | 0.1805 |
| Akari Therapeutics PLC | -- |
| Merus NV | 0.00 |